BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $685,000 | -37.7% | 84,855 | -41.1% | 0.01% | -25.0% |
| Q3 2018 | $1,099,000 | +33.2% | 144,000 | 0.0% | 0.01% | +33.3% |
| Q2 2018 | $825,000 | +20.1% | 144,000 | 0.0% | 0.01% | +20.0% |
| Q1 2018 | $687,000 | -2.8% | 144,000 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $707,000 | -6.4% | 144,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $755,000 | -5.7% | 144,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $801,000 | -33.8% | 144,000 | 0.0% | 0.01% | -37.5% |
| Q1 2017 | $1,210,000 | +32.7% | 144,000 | 0.0% | 0.01% | +33.3% |
| Q4 2016 | $912,000 | +29.2% | 144,000 | -10.0% | 0.01% | +20.0% |
| Q3 2016 | $706,000 | +55.5% | 160,000 | 0.0% | 0.01% | +66.7% |
| Q2 2016 | $454,000 | +0.2% | 160,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $453,000 | – | 160,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |